Progyny (PGNY) announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026. These offerings complement the availability of the company’s existing and marketing-leading global fertility and family building offering, providing multi-national employers with a continuum of integrated services. Progyny’s localized global expertise and member-first experience are supporting unmet needs across pivotal women’s and family life stages.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Trump Weekly: U.S. threatens China with 100% tariff over rare earth controls
- Trump Trade: Trump says cost of GLP-1 drugs to come down ‘pretty fast’
- Trump’s possible IVF action an incremental positive for Progyny, says BofA
- White House to seek to make IVF more accessible, NY Times reports
- Progyny price target raised to $25 from $23 at JPMorgan